What is Denali Therapeutics Inc.'s capex?

Denali Therapeutics Inc. (DNLI) reported capex of $2.47M in Q1 2026.

How has Denali Therapeutics Inc.'s capex changed year-over-year?

Denali Therapeutics Inc.'s capex decreased by 51.4% year-over-year, from $5.08M to $2.47M.

What is the long-term trend for Denali Therapeutics Inc.'s capex?

Over 3 years (2021 to 2024), Denali Therapeutics Inc.'s capex has grown at a 23.2% compound annual growth rate (CAGR), from $8.5M to $15.91M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Denali Therapeutics Inc. DNLI CapEx

CapEx at other companies

Eli LillyLLY

$2.33B+54.0%

Regeneron PharmaceuticalsREGN

$230.6M+0.6%

Acadia PharmaceuticalsACAD

$5.21M—

BridgeBio PharmaBBIO

$69K—

BiogenBIIB

$51.2M+38.0%

PTC TherapeuticsPTCT

$1.2M-30.6%

Other financials

Income statement

See full

Revenue-—

Operating income-$137.4M+5.6%

Net income-$128.4M+3.4%

EPS (diluted)-$0.69+11.5%

Balance sheet

See full

Cash & equivalents$390.7M+551%

Total debt$40.0M-22.3%

Total equity$926.1M-17.5%

Total assets$1.3B-0.4%

Cash flow

See full

Operating cash flow-$131.2M+0.2%

Free cash flow-$133.7M+2.1%

Valuation

See full

Market cap$3.7B+54.2%

Enterprise value$3.35B+37.1%

Profitability

See full

Operating margin-37,938%-37,986pp

Net margin-33,121.9%-33,159pp

FCF margin-31,736.3%-31,830pp

Returns & leverage

See full

Return on equity-49.6%+34.2pp

Debt / equity0×0.0×

Current ratio9.3×-0.3×

Where this comes from

Reported directly by Denali Therapeutics Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Denali Therapeutics Inc.'s capex?: Denali Therapeutics Inc. (DNLI) reported capex of $2.47M in Q1 2026.
How has Denali Therapeutics Inc.'s capex changed year-over-year?: Denali Therapeutics Inc.'s capex decreased by 51.4% year-over-year, from $5.08M to $2.47M.
What is the long-term trend for Denali Therapeutics Inc.'s capex?: Over 3 years (2021 to 2024), Denali Therapeutics Inc.'s capex has grown at a 23.2% compound annual growth rate (CAGR), from $8.5M to $15.91M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.